RAAB MICHAEL

CIK 00013214024 companiesWALTHAM, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001321402

Recent Transactions

50 trades

Sale
ARDELYX, INC.$ARDX
Common Stock
2026-07-15$5.06/sh−41,668→ 1,678,366 total
Exercise/Conversion
ARDELYX, INC.$ARDX
Stock Option (Right to Buy)
2026-07-15−20,834→ 290,834 total
Exercise/Conversion
ARDELYX, INC.$ARDX
Common Stock
2026-07-15$0.99/sh+20,834→ 1,720,034 total
Sale
ARDELYX, INC.$ARDX
Common Stock
2026-06-15$5.67/sh−41,666→ 1,699,200 total
Exercise/Conversion
ARDELYX, INC.$ARDX
Common Stock
2026-06-15$0.99/sh+20,833→ 1,740,866 total
Exercise/Conversion
ARDELYX, INC.$ARDX
Stock Option (Right to Buy)
2026-06-15−20,833→ 311,668 total
Sale
ARDELYX, INC.$ARDX
Common Stock
2026-05-21$6.27/sh−7,861→ 1,751,987 total
Sale
ARDELYX, INC.$ARDX
Common Stock
2026-05-21$6.27/sh−14,933→ 1,759,848 total
Sale
ARDELYX, INC.$ARDX
Common Stock
2026-05-21$6.27/sh−17,926→ 1,734,061 total
Sale
ARDELYX, INC.$ARDX
Common Stock
2026-05-21$6.27/sh−14,028→ 1,720,033 total
Exercise/Conversion
ARDELYX, INC.$ARDX
Stock Option (Right to Buy)
2026-05-15−20,833→ 332,501 total
Exercise/Conversion
ARDELYX, INC.$ARDX
Common Stock
2026-05-15$0.99/sh+20,833→ 1,816,447 total
Sale
ARDELYX, INC.$ARDX
Common Stock
2026-05-15$6.28/sh−41,666→ 1,774,781 total
Disposition to Issuer
AMICUS THERAPEUTICS, INC.$FOLD
Stock Options (right to buy)
2026-04-27−18,574→ 0 total
Disposition to Issuer
AMICUS THERAPEUTICS, INC.$FOLD
Stock Options (right to buy)
2026-04-27−36,111→ 0 total
Disposition to Issuer
AMICUS THERAPEUTICS, INC.$FOLD
Stock Options (right to buy)
2026-04-27−19,473→ 0 total
Disposition to Issuer
AMICUS THERAPEUTICS, INC.$FOLD
Common Stock
2026-04-27$14.50/sh−115,857→ 0 total
Disposition to Issuer
AMICUS THERAPEUTICS, INC.$FOLD
Stock Options (right to buy)
2026-04-27−20,000→ 0 total
Disposition to Issuer
AMICUS THERAPEUTICS, INC.$FOLD
Stock Options (right to buy)
2026-04-27−45,423→ 0 total
Disposition to Issuer
AMICUS THERAPEUTICS, INC.$FOLD
Stock Options (right to buy)
2026-04-27−42,467→ 0 total
Disposition to Issuer
AMICUS THERAPEUTICS, INC.$FOLD
Stock Options (right to buy)
2026-04-27−16,236→ 0 total
Disposition to Issuer
AMICUS THERAPEUTICS, INC.$FOLD
Stock Options (right to buy)
2026-04-27−74,872→ 0 total
Disposition to Issuer
AMICUS THERAPEUTICS, INC.$FOLD
Stock Options (right to buy)
2026-04-27−30,474→ 0 total
Exercise/Conversion
ARDELYX, INC.$ARDX
Common Stock
2026-04-15$0.99/sh+20,834→ 1,837,282 total
Sale
ARDELYX, INC.$ARDX
Common Stock
2026-04-15$6.29/sh−41,668→ 1,795,614 total
Exercise/Conversion
ARDELYX, INC.$ARDX
Stock Option (Right to Buy)
2026-04-15−20,834→ 353,334 total
Exercise/Conversion
ARDELYX, INC.$ARDX
Stock Option (Right to Buy)
2026-03-16−20,833→ 374,168 total
Sale
ARDELYX, INC.$ARDX
Common Stock
2026-03-16$5.84/sh−41,666→ 1,816,448 total
Exercise/Conversion
ARDELYX, INC.$ARDX
Common Stock
2026-03-16$0.99/sh+20,833→ 1,856,986 total
Sale
ARDELYX, INC.$ARDX
Common Stock
2026-02-24$6.25/sh−41,666→ 1,836,153 total
Exercise/Conversion
ARDELYX, INC.$ARDX
Stock Option (Right to Buy)
2026-02-24−20,833→ 395,001 total
Exercise/Conversion
ARDELYX, INC.$ARDX
Common Stock
2026-02-24$0.99/sh+20,833→ 1,877,819 total
Sale
ARDELYX, INC.$ARDX
Common Stock
2026-02-20$5.87/sh−40,401→ 1,862,567 total
Sale
ARDELYX, INC.$ARDX
Common Stock
2026-02-20$5.71/sh−5,576→ 1,856,991 total
Sale
ARDELYX, INC.$ARDX
Common Stock
2026-02-20$5.70/sh−2→ 1,856,989 total
Sale
ARDELYX, INC.$ARDX
Common Stock
2026-02-20$5.70/sh−1→ 1,856,988 total
Sale
ARDELYX, INC.$ARDX
Common Stock
2026-02-20$5.70/sh−2→ 1,856,986 total
Award
Tempest Therapeutics, Inc.$TPST
Stock Option (right to buy)
2026-01-27+1,230→ 1,230 total
Award
ARDELYX, INC.$ARDX
Common Stock
2026-01-23+446,220→ 1,902,968 total
Award
ARDELYX, INC.$ARDX
Stock Option (Right to Buy)
2026-01-23+669,330→ 669,330 total
Sale
ARDELYX, INC.$ARDX
Common Stock
2025-11-21$5.54/sh−46,887→ 1,455,363 total
Sale
ARDELYX, INC.$ARDX
Common Stock
2025-08-21$5.93/sh−45,687→ 1,502,250 total
Award
AMICUS THERAPEUTICS, INC.$FOLD
Stock Options (right to buy)
2025-06-05+74,872→ 74,872 total
Award
AMICUS THERAPEUTICS, INC.$FOLD
Common Stock
2025-06-05+20,414→ 115,857 total
Sale
ARDELYX, INC.$ARDX
Common Stock
2025-05-20$4.08/sh−46,817→ 1,547,937 total
Exercise/Conversion
ARDELYX, INC.$ARDX
Common Stock
2025-05-02$0.99/sh+20,833→ 1,636,420 total
Exercise/Conversion
ARDELYX, INC.$ARDX
Stock Option (Right to Buy)
2025-05-02−20,833→ 415,834 total
Sale
ARDELYX, INC.$ARDX
Common Stock
2025-05-02$4.25/sh−41,666→ 1,594,754 total
Exercise/Conversion
ARDELYX, INC.$ARDX
Common Stock
2025-04-04$0.99/sh+20,833→ 1,657,253 total
Sale
ARDELYX, INC.$ARDX
Common Stock
2025-04-04$4.59/sh−41,666→ 1,615,587 total

Companies

Recent Filings

Address

C/O ARDELYX, INC. 400 FIFTH AVENUE, SUITE 210

WALTHAM, MA, 02451

View on SEC.gov